Annual Total Expenses
$236.72 M
+$28.79 M+13.85%
December 1, 2024
Summary
- As of March 10, 2025, XERS annual total expenses is $236.72 million, with the most recent change of +$28.79 million (+13.85%) on December 1, 2024.
- During the last 3 years, XERS annual total expenses has risen by +$71.97 million (+43.69%).
- XERS annual total expenses is now at all-time high.
Performance
XERS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$58.42 M
-$8.74 M-13.01%
December 31, 2024
Summary
- As of March 10, 2025, XERS quarterly total expenses is $58.42 million, with the most recent change of -$8.74 million (-13.01%) on December 31, 2024.
- Over the past year, XERS quarterly total expenses has stayed the same.
- XERS quarterly total expenses is now -16.18% below its all-time high of $69.70 million, reached on December 31, 2021.
Performance
XERS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
XERS Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | 0.0% |
| 3 y3 years | +43.7% | +9.7% |
| 5 y5 years | +89.2% | +9.7% |
XERS Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.7% | -16.2% | +32.1% |
| 5 y | 5-year | at high | +127.7% | -16.2% | +152.4% |
| alltime | all time | at high | +1554.7% | -16.2% | +1067.7% |
Xeris Biopharma Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $58.42 M(-13.0%) |
| Dec 2024 | $236.72 M(+13.8%) | - |
| Sep 2024 | - | $67.16 M(+19.4%) |
| Jun 2024 | - | $56.25 M(+2.5%) |
| Mar 2024 | - | $54.88 M(+1.2%) |
| Dec 2023 | $207.92 M(+8.2%) | $54.23 M(+1.9%) |
| Sep 2023 | - | $53.23 M(-1.4%) |
| Jun 2023 | - | $53.99 M(+16.2%) |
| Mar 2023 | - | $46.47 M(-3.8%) |
| Dec 2022 | $192.19 M(+16.7%) | $48.31 M(-0.4%) |
| Sep 2022 | - | $48.51 M(+9.7%) |
| Jun 2022 | - | $44.22 M(-13.5%) |
| Mar 2022 | - | $51.15 M(-26.6%) |
| Dec 2021 | $164.75 M(+58.4%) | $69.70 M(+96.8%) |
| Sep 2021 | - | $35.42 M(+2.1%) |
| Jun 2021 | - | $34.69 M(+39.1%) |
| Mar 2021 | - | $24.93 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $103.98 M(-16.9%) | $26.71 M(+15.4%) |
| Sep 2020 | - | $23.15 M(-4.5%) |
| Jun 2020 | - | $24.23 M(-19.0%) |
| Mar 2020 | - | $29.93 M(-13.7%) |
| Dec 2019 | $125.10 M(+102.5%) | $34.66 M(+14.0%) |
| Sep 2019 | - | $30.39 M(-11.5%) |
| Jun 2019 | - | $34.36 M(+33.8%) |
| Mar 2019 | - | $25.68 M(+21.9%) |
| Dec 2018 | $61.77 M(+119.1%) | $21.07 M(+35.7%) |
| Sep 2018 | - | $15.53 M(+17.8%) |
| Jun 2018 | - | $13.18 M(+9.9%) |
| Mar 2018 | - | $11.99 M(+23.9%) |
| Dec 2017 | $28.18 M(+97.0%) | $9.68 M(+25.0%) |
| Sep 2017 | - | $7.74 M(+34.3%) |
| Jun 2017 | - | $5.76 M(+15.2%) |
| Mar 2017 | - | $5.00 M |
| Dec 2016 | $14.31 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total expenses?
- What is the all time high annual total expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual total expenses year-on-year change?
- What is Xeris Biopharma Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly total expenses year-on-year change?
What is Xeris Biopharma Holdings annual total expenses?
The current annual total expenses of XERS is $236.72 M
What is the all time high annual total expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total expenses is $236.72 M
What is Xeris Biopharma Holdings annual total expenses year-on-year change?
Over the past year, XERS annual total expenses has changed by +$28.79 M (+13.85%)
What is Xeris Biopharma Holdings quarterly total expenses?
The current quarterly total expenses of XERS is $58.42 M
What is the all time high quarterly total expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total expenses is $69.70 M
What is Xeris Biopharma Holdings quarterly total expenses year-on-year change?
Over the past year, XERS quarterly total expenses has changed by $0.00 (0.00%)